首页 >
法规速递
-
中药保护品种公告（第31号）（2025年第97号）-2025/10/9
2025-10-10查看详情 > -
国家药监局关于深化化妆品监管改革促进产业高质量发展的意见-2025/11/17
2025-11-18查看详情 > -
Document: Agenda – Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) (17 December 2025)-2025/12/11
2025-12-12查看详情 > -
Document: Concept paper on the development of a guideline for using owner assessment as efficacy parameter-2026/1/23
2026-01-26查看详情 > -
Document: Human medicines highlights 2022-2026/3/3
2026-03-04查看详情 > -
Document: Annex 1 - Standard Operating Procedure for the Implementation of Virtual Control Groups in Preclinical Studies-2026/3/31
2026-04-01查看详情 > -
Document: Timetable accelerated assessment request for initial marketing authorisation applications-2026/5/13
2026-05-14查看详情 > -
关于公开征求《化学仿制药参比制剂目录（第一百零八批）》（征求意见稿）意见的通知-2026/6/26
2026-06-29查看详情 > -
Q5A(R2) Viral Safety Evaluation of Biotechnology Products Derived From Cell Lines of Human or Animal Origin (Draft)-2022/11/10
2022-11-30查看详情 > -
国家药监局综合司公开征求《关于加强委托生产药品上市许可持有人监管工作的通知 （征求意见稿）》意见-2023/5/24
2023-05-24查看详情 >
